Activation of Lipoprotein Lipase by Glucose-dependent Insulinotropic Polypeptide in Adipocytes
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Glucose-dependent insulinotropic polypeptide (GIP) has been mainly studied because of its glucose-dependent insulinotropic action and its ability to regulate beta-cell proliferation and survival. Considerably less is known about the effects of GIP on fat metabolism, and the present study was directed at identifying the mechanisms underlying its stimulatory action on lipoprotein lipase (LPL). In differentiated 3T3-L1 adipocytes, GIP, in the presence of insulin, increased LPL activity and triglyceride accumulation through a pathway involving increased phosphorylation of protein kinase B (PKB) and reductions in phosphorylated LKB1 and AMP-activated protein kinase (AMPK). Knockdown of AMPK using RNA interference and application of the AMPK inhibitor, Compound C, supported this conclusion. In contrast, the other major incretin hormone, glucagon-like peptide-1, exhibited no significant effects on LPL activity or PKB, LKB1, or AMPK phosphorylation. Cultured subcutaneous human adipocytes showed similar responses to GIP but with greater sensitivity. Chronic elevation of circulating GIP levels in the Vancouver diabetic fatty Zucker rat in vivo resulted in increased LPL activity and elevated triglyceride accumulation in epididymal fat tissue, combined with a modulation of PKB, LKB1, and AMPK phosphorylation similar to that observed in vitro. This appears to be the first demonstration of a GIP-stimulated signal transduction pathway involved in increasing fat storage in adipocytes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, treatment of diet-induced obese mice with a GCGR agonist revealed that glucagon-stimulated energy expenditure and weight loss can also be driven by hepatic amino acid catabolism, and thus a systemic response to hypoaminoacidemia74”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [74]
In the citing paper
“However, based on the lipogenetic properties205, 206, 207 of GIP, insufficient insulin-potentiating effects in T2DM patients220, 336 and a possible worsening effect by GIP,337, 338 the focus is on GLP-1 analogues/receptor agonists for T2DM treatment.”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [207]
In the citing paper
“GIP promotes lipogenesis and lipid deposition under conditions of hyperinsulinema [34–36] while stimulating lipolysis and fatty acid oxidation under conditions of normo- or hypoinsulinemia [37–39].”
From Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes (2024) · cites this paper as [34]
Citations
Cites
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Mechanism of activation of protein kinase B by insulin and IGF-1.
Alessi, D. R., Andjelkovic, M., Caudwell, B., Cron, P., Morrice, N., Cohen, P., & Hemmings, B. A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01045.x · Cited by 3,004
LKB1 is the upstream kinase in the AMP-activated protein kinase cascade
Woods, A., Johnstone, S. R., Dickerson, K., Leiper, F. C., Fryer, L. G. D., Neumann, D., Schlattner, U., Wallimann, T., Carlson, M., & Carling, D. (2003) · Current Biology · doi:10.1016/j.cub.2003.10.031 · Cited by 1,650
The AMP‐Activated Protein Kinase: Fuel Gauge of the Mammalian Cell?
Hardie, D. G., & Carling, D. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00259.x · Cited by 1,317
The AMP-activated protein kinase cascade – a unifying system for energy control
Carling, D. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.11.005 · Cited by 1,112
Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis
Goldberg, I. J. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37569-6 · Cited by 1,010
Ram�rez-Zacar�as, J. L., Castro-Mu�ozledo, F., & Kuri-Harcuch, W. (1992) · Histochemistry · doi:10.1007/bf00316069 · Cited by 1,008
Inhibition of gastric inhibitory polypeptide signaling prevents obesity
Miyawaki, K., Yamada, Y., Ban, N., Ihara, Y., Tsukiyama, K., Zhou, H., Fujimoto, S., Oku, A., Tsuda, K., Toyokuni, S., et al. (2002) · Nature Medicine · doi:10.1038/nm727 · Cited by 963
AMP-Activated Protein Kinase – Development of the Energy Sensor Concept
Hardie, D. G., Hawley, S. A., & Scott, J. W. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.108944 · Cited by 813
The regulation of AMP-activated protein kinase by phosphorylation
STEIN, S. C., Woods, A., Jones, N. A., DAVISON, M. D., & Carling, D. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3450437 · Cited by 605
Usdin, T. B., Mezey, E., Button, D. C., Brownstein, M. J., & Bonner, T. I. (1993) · Endocrinology · doi:10.1210/endo.133.6.8243312 · Cited by 534
Merkel, M., Eckel, R. H., & Goldberg, I. J. (2002) · Journal of Lipid Research · doi:10.1194/jlr.r200015-jlr200 · Cited by 522
Functions of AMP‐activated protein kinase in adipose tissue
Daval, M., Foufelle, F., & Ferré, P. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.111484 · Cited by 417
Akt Activity Negatively Regulates Phosphorylation of AMP-activated Protein Kinase in the Heart
Kovacic, S., Soltys, C.-L. M., Barr, A. J., Shiojima, I., Walsh, K., & Dyck, J. R. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305371200 · Cited by 406
Woods, A., Azzout-Marniche, D., Foretz, M., Stein, S. C., Lemarchand, P., Ferré, P., Foufelle, F., & Carling, D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.18.6704-6711.2000 · Cited by 403
Horman, S., Vertommen, D., Heath, R., Neumann, D., Mouton, V., Woods, A., Schlattner, U., Wallimann, T., Carling, D., Hue, L., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m506850200 · Cited by 344
Anti-lipolytic Action of AMP-activated Protein Kinase in Rodent Adipocytes
Daval, M., Diot-Dupuy, F., Bazin, R., Hainault, I., Viollet, B., Vaulont, S., Hajduch, E., Ferré, P., & Foufelle, F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414222200 · Cited by 324
Regulation of the synthesis, processing and translocation of lipoprotein lipase
Braun, J. E. A., & Severson, D. L. (1992) · Biochemical Journal · doi:10.1042/bj2870337 · Cited by 319
Glucagon-like peptide 1(GLP-1) in biology and pathology
Meier, J. J., & Nauck, M. A. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.538 · Cited by 288
Drucker, D. J. (2003) · Endocrinology · doi:10.1210/en.2003-1147 · Cited by 274
GIF biology and fat metabolism
Yip, R. G. C., & Wolfe, M. M. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00314-8 · Cited by 266
Hurley, R. L., Barré, L. K., Wood, S. D., Anderson, K. A., Kemp, B. E., Means, A. R., & Witters, L. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606676200 · Cited by 263
Semenkovich, C. F., Wims, M., Noe, L., Etienne, J., & Chan, L. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81898-1 · Cited by 249
Kim, S.-J., Winter, K., Nian, C., Tsuneoka, M., Koda, Y., & McIntosh, C. H. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500540200 · Cited by 241
Self-citationPreiss-Landl, K., Zimmermann, R., Hämmerle, G., & Zechner, R. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200210000-00002 · Cited by 240
Trümper, A., Trümper, K., Trusheim, H., Arnold, R., Göke, B., & Hörsch, D. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.9.0688 · Cited by 238
Functional GIP Receptors Are Present on Adipocytes
Yip, R. G.-C., Boylan, M. O., Kieffer, T. J., & Wolfe, M. M. (1998) · Endocrinology · doi:10.1210/endo.139.9.6288 · Cited by 237
Pospisilik, J. A., Stafford, S. G., Demuth, H.-U., Brownsey, R., Parkhouse, W., Finegood, D. T., McIntosh, C. H. S., & Pederson, R. A. (2002) · Diabetes · doi:10.2337/diabetes.51.4.943 · Cited by 232
Self-citationGastric Inhibitory Polypeptide Enhanced Lipoprotein Lipase Activity in Cultured Preadipocytes
Eckel, R. H., Fujimoto, W. Y., & Brunzell, J. D. (1979) · Diabetes · doi:10.2337/diab.28.12.1141 · Cited by 219
Encyclopedia of Endocrine Diseases
(2019) · Elsevier eBooks · doi:10.1016/c2016-1-01662-0 · Cited by 198
Oben, J., Morgan, L., Fletcher, J., & Marks, V. (1991) · Journal of Endocrinology · doi:10.1677/joe.0.1300267 · Cited by 188
Gastric Inhibitory Polypeptide
Brown, J. C. (1982) · Monographs on endocrinology · doi:10.1007/978-3-642-81771-7 · Cited by 171
Ehses, J. A., Casilla, V. R., Doty, T., Pospisilik, J. A., Winter, K. D., Demuth, H.-U., Pederson, R. A., & McIntosh, C. H. S. (2003) · Endocrinology · doi:10.1210/en.2002-0068 · Cited by 159
Self-citationEffect of gastric inhibitory polypeptide on plasma levels of chylomicron triglycerides in dogs.
Wasada, T., McCorkle, K., Harris, V, Kawai, K., Howard, B., & Unger, R. H. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110335 · Cited by 153
King, T. D., Song, L., & Jope, R. S. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.03.005 · Cited by 145
Ehses, J. A., Pelech, S. L., Pederson, R. A., & McIntosh, C. H. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205055200 · Cited by 133
Self-citationSalt, I. P., Connell, J. M., & Gould, G. W. (2000) · Diabetes · doi:10.2337/diabetes.49.10.1649 · Cited by 132
Wheeler, M. B., Gelling, R. W., McIntosh, C. H., Georgiou, J., Brown, J. C., & Pederson, R. A. (1995) · Endocrinology · doi:10.1210/endo.136.10.7664683 · Cited by 130
Self-citationBiological activities of des-His1[Glu9]glucagon amide, a glucagon antagonist
Unson, C. G., Gurzenda, E. M., & Merrifield, R. B. (1989) · Peptides · doi:10.1016/0196-9781(89)90010-7 · Cited by 126
Fediuc, S., Gaidhu, M. P., & Ceddia, R. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m500438-jlr200 · Cited by 120
Knapper, J. M. E., Puddicombe, S. M., Morgan, L. M., & Fletcher, J. M. (1995) · The Journal of Nutrition · doi:10.1093/jn/125.2.183 · Cited by 109
Beck, B., & Max, J. (1983) · Regulatory Peptides · doi:10.1016/0167-0115(83)90276-8 · Cited by 91
Gut Peptides: Biochemistry and Physiology
Rehfeld, J. F. (1994) · Gut · doi:10.1136/gut.35.12.1774 · Cited by 88
Montrose-Rafizadeh, C., Yang, H., Wang, Y., Roth, J., Montrose, M. H., & Adams, L. G. (1997) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199709)172:3<275::aid-jcp1>3.0.co;2-l · Cited by 86
McIntosh, C. H. S., Bremsak, I., Lynn, F. C., Gill, R., Hinke, S. A., Gelling, R., Nian, C., McKnight, G., Jaspers, S., & Pederson, R. A. (1999) · Endocrinology · doi:10.1210/endo.140.1.6464 · Cited by 73
Self-citationThe Encyclopedia of Endocrine Diseases
Gerver, W. J. M. (2004) · Cited by 73
Bergö, M., Wu, G., Ruge, T., & Olivecrona, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200325200 · Cited by 69
A New Pathway for Glucose-dependent Insulinotropic Polypeptide (GIP) Receptor Signaling
Ehses, J. A., Lee, S. S. T., Pederson, R. A., & McIntosh, C. H. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103023200 · Cited by 61
Self-citationLocalization of Lipoprotein Lipase in the Diabetic Heart
Sambandam, N., Abrahani, M. A., Pierre, E. S., Al-Atar, O., Cam, M. C., & Rodrigues, B. B. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.6.1526 · Cited by 58
The metabolic role of GIP: physiology and pathology
Morgan, L. M. (1996) · Biochemical Society Transactions · doi:10.1042/bst0240585 · Cited by 55
Inhibition of actions of glucagon in adipocytes by gastric inhibitory polypeptide
Dupre, J., Greenidge, N., McDonald, T. J., Ross, S. A., & Rubinstein, D. (1976) · Metabolism · doi:10.1016/s0026-0495(76)80002-9 · Cited by 53
Sponarova, J., Mustard, K. J., Horakova, O., Flachs, P., Rossmeisl, M., Brauner, P., Bardova, K., Thomason-Hughes, M., Braunerova, R., Janovska, P., et al. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.09.078 · Cited by 48
LKB1: a sweet side to Peutz–Jeghers syndrome?
Carling, D. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.02.003 · Cited by 25
Response of gastric inhibitory polypeptide to fat ingestion in normal dogs
Ohneda, A., Kobayashi, T., & Nihei, J. (1984) · Regulatory Peptides · doi:10.1016/0167-0115(84)90167-8 · Cited by 14
Rh, E., Fujimoto, W. Y., & Jd, B. (1981) · PubMed · Cited by 11
GIP (Gastric Inhibitory Polypeptide)
Pederson, R. A., & McIntosh, C. H. S. (2004) · Elsevier eBooks · doi:10.1016/b0-12-475570-4/00528-x · Cited by 7
Self-citation
Research works printed but not linked: 7
- Pederson, 2004, Vol. 2, 202
- Knapper, 1995, J. Nutr., 125, 183
- Trümper, 2001, Mol. Endocrinol., 15, 1559
- Stein, 2000, Biochem. J., 345, 437, 10.1042/bj3450437 · DOI · Paper page
- Kim, 2006, Cell. Signal.
- An, 2005, Am. J. Physiol., 288, E246
- Eckel, 1981, Int. J. Obes., 5, 571
Cited by
Pancreatic regulation of glucose homeostasis.
Röder, P. V., Wu, B., Liu, Y., & Han, W. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.6 · Cited by 985
Coskun, T., Sloop, K. W., Loghin, C., Alsina-Fernandez, J., Urva, S., Bokvist, K. B., Cui, X., Briere, D. A., Cabrera, O., Roell, W. C., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.09.009 · Cited by 882
The role of incretins in glucose homeostasis and diabetes treatment
Kim, W., & Egan, J. M. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.000604 · Cited by 824
“…AMP-activated protein kinase phosphorylation in differentiated 3T3-L1, cultured subcutaneous human adipocytes, and epidermal fat tissue of the VDF Zucker rat (Kim et al., 2007b) and these effects of GIP are mediated through the direct regulation of adipokine resistin release (Kim et al., 2007c).”
BackgroundResultGIP and GLP-1, the two incretin hormones: Similarities and differences
Seino, Y., Fukushima, M., & Yabe, D. (2010) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00022.x · Cited by 746
Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans
Finan, B., Ma, T., Ottaway, N., Müller, T. D., Habegger, K. M., Heppner, K. M., Kirchner, H., Holland, J., Hembree, J., Raver, C., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007218 · Cited by 696
Metadata
- Authors
- Kim, S.-J., Nian, C., & McIntosh, C. H. S.
- Affiliations
- University of British Columbia (CA)
- Corresponding author
- McIntosh, Christopher H.S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-03
- Volume
- 282
- Issue
- 12
- Pages
- 8557-8567
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2079889142
- Cited by
- 216
- References
- 56
- Citations by year
- 2026: 10 · 2025: 14 · 2024: 18 · 2023: 12 · 2022: 7 · 2021: 8 · 2020: 17 · 2019: 13 · 2018: 13 · 2017: 11 · 2016: 5 · 2015: 5 · 2014: 7 · 2013: 9 · 2012: 10
- FWCI
- 9.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4964 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- glucose-dependent insulinotropic polypeptide, lipoprotein lipase, adipocytes, triglyceride accumulation, Akt, LKB1, AMPK, AMPK inhibition, glucagon-like peptide-1, fat metabolism, signal transduction, 3T3-L1 adipocytes, epididymal adipose tissue
- MeSH terms
- AMP-Activated Protein Kinase Kinases, Animals, Enzyme Activation, Gastric Inhibitory Polypeptide, Glucose, Humans, Lipoprotein Lipase, Multienzyme Complexes, Rats, Zucker, Protein Serine-Threonine Kinases, Adipocytes, 3T3-L1 Cells, Proto-Oncogene Proteins c-akt, Mice, Rats, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.